|
|
FUNCTIONS OF HOPX IN IMMUNE TOLERANCE IN A MODEL OF MULTIPLE SCLEROSIS |
| 5R01AI113903-03 |
HAWIGER, DANIEL |
NIAID |
2016 |
|
|
METABOLIC PROGRAMMING IN TH17 CELL DIFFERENTIATION |
| 5R01AI114581-02 |
WANG, RUONING |
NIAID |
2016 |
|
|
GENETICALLY MODIFIED HSC-HPC FOR MANAGEMENT OF AGGRESSIVE DEMYELINATING DISEASES |
| 5R21AI103701-02 |
STROMINGER, JACK L |
NIAID |
2016 |
|
|
MECHANISM OF MALT1 REGULATION BY A NOVEL UBIQUITIN LIGASE |
| 5R21AI111045-02 |
LI, HONGMIN |
NIAID |
2016 |
|
|
INFECTION PREVENTION IN TOTAL KNEE REPLACEMENT |
| 5R21AI115416-02 |
BECHTOLD, JOAN E |
NIAID |
2016 |
|
|
HUR REGULATES TH17 CELLS FOR PROMOTING AUTOIMMUNE NEUROINFLAMMATION |
| 7R01AI119135-02 |
YU, SHIGUANG |
NIAID |
2016 |
|
|
NOVEL THERAPEUTIC AGENT TO PREVENT HEARING LOSS DURING AMINOGLYCOSIDE THERAPY |
| 9R44AI122428-02A1 |
GLESER, MALCOLM |
NIAID |
2016 |
